Safety of flavivirus chimeric vaccines: Answer to Ishikawa et al. [Vaccine 26 (22) (2008) 2772-2781]

被引:8
作者
Guy, Bruno [1 ]
Guirakhoo, Farshad [1 ]
Watson, Michael [2 ]
Higgs, Stephen [3 ,4 ]
机构
[1] Sanofi Pasteur, Marcy Letoile, France
[2] Acambis, Cambridge, MA USA
[3] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA
[4] Univ Texas Med Branch, WHO, Collaborating Ctr Trop Dis, Galveston, TX 77555 USA
关键词
vaccine; chimera; flavivirus; safety;
D O I
10.1016/j.vaccine.2008.05.056
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:4107 / 4108
页数:2
相关论文
共 18 条
[1]   Yellow fever vector live-virus vaccines: West Nile virus vaccine development [J].
Arroyo, J ;
Miller, CA ;
Catalan, J ;
Monath, TP .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (08) :350-354
[2]   Molecular basis for attenuation of neurovirulence of a yellow fever virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE) [J].
Arroyo, J ;
Guirakhoo, F ;
Fenner, S ;
Zhang, ZX ;
Monath, TP ;
Chambers, TJ .
JOURNAL OF VIROLOGY, 2001, 75 (02) :934-942
[3]   High stability of yellow fever 17D-204 vaccine:: A 12-year restrospective analysis of large-scale production [J].
Barban, V. ;
Girerd, Y. ;
Aguirre, A. ;
Gulia, S. ;
Petiard, F. ;
Riou, P. ;
Barrere, B. ;
Lang, J. .
VACCINE, 2007, 25 (15) :2941-2950
[4]   Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax™-JE (YF/JE SAL4-14-2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes [J].
Bhatt, TR ;
Crabtree, MB ;
Guirakhoo, F ;
Monath, TP ;
Miller, BR .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2000, 62 (04) :480-484
[5]   Replication of chimeric yellow fever virus-Dengue serotype 1-4 virus vaccine strains in dendritic and hepatic cells [J].
Brandler, S ;
Brown, N ;
Ermak, TH ;
Mitchell, F ;
Parsons, M ;
Zhang, ZX ;
Lang, J ;
Monath, TP ;
Guirakhoo, F .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 72 (01) :74-81
[6]   Yellow fever Japanese encephalitis chimeric viruses: Construction and biological properties [J].
Chambers, TJ ;
Nestorowicz, A ;
Mason, PW ;
Rice, CM .
JOURNAL OF VIROLOGY, 1999, 73 (04) :3095-3101
[7]  
DOSSANTOS CND, 1995, VIRUS RES, V35, P35
[8]   Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates [J].
Guirakhoo, F ;
Pugachev, K ;
Zhang, Z ;
Myers, G ;
Levenbook, I ;
Draper, K ;
Lang, J ;
Ocran, S ;
Mitchell, F ;
Parsons, M ;
Brown, N ;
Brandler, S ;
Fournier, C ;
Barrere, B ;
Rizvi, F ;
Travassos, A ;
Nichols, R ;
Trent, D ;
Monath, T .
JOURNAL OF VIROLOGY, 2004, 78 (09) :4761-4775
[9]   COMPARISON OF THE VIRULENT ASIBI STRAIN OF YELLOW-FEVER VIRUS WITH THE 17D VACCINE STRAIN DERIVED FROM IT [J].
HAHN, CS ;
DALRYMPLE, JM ;
STRAUSS, JH ;
RICE, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (07) :2019-2023
[10]   Growth characteristics of ChimeriVax-DEN vaccine viruses in Aedes aegypti and Aedes albopictus from Thailand [J].
Higgs, Stephen ;
Vanlandingham, Dana L. ;
Klingler, Kimberly A. ;
McElroy, Kate L. ;
McGee, Charles E. ;
Harrington, Laura ;
Lang, Jean ;
Monath, Thomas P. ;
Guirakhoo, Farshad .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05) :986-993